Quest Diagnostics Profit Margin 2010-2023 | DGX

Current and historical gross margin, operating margin and net profit margin for Quest Diagnostics (DGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Quest Diagnostics net profit margin as of December 31, 2023 is 9.23%.
Quest Diagnostics Annual Profit Margins
Quest Diagnostics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $14.102B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $15.996B 9.68
DaVita (DVA) United States $11.194B 15.23
Chemed (CHE) United States $9.133B 28.74
Encompass Health (EHC) United States $7.980B 21.89
Elanco Animal Health (ELAN) United States $6.611B 15.07
Option Care Health (OPCH) United States $5.261B 20.59
RadNet (RDNT) United States $3.273B 95.60
Amedisys (AMED) United States $2.971B 21.20
LifeStance Health (LFST) United States $2.166B 0.00
Astrana Health (ASTH) United States $2.073B 26.16
Addus HomeCare (ADUS) United States $1.568B 24.03
U.S Physical Therapy (USPH) United States $1.478B 38.33
Pennant (PNTG) United States $0.608B 35.10
Aveanna Healthcare Holdings (AVAH) United States $0.427B 0.00
Atai Life Sciences (ATAI) Germany $0.329B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.010B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00